Aristolochia tagala
Aristolochia tagala
Aristolochia tagala is a medicinal plant species utilized by the Kani tribes in the Thodu hills of Kerala. In these traditional practices, it is applied to address fever, swelling, tympanitis, dermatosis, and as a carminative or philter. Preliminary scientific studies suggest the plant may possess antioxidant, anti-inflammatory, and anticancer properties, potentially through the modulation of TNF-alpha and NF-kappaB pathways. Some research also indicates potential anti-carcinogenic effects in mouse models and suggests a lack of acute nephrotoxicity at certain tested doses. No major safety issues or notable drug interactions have been recorded in the available data.
- Traditionally for
- carminative · dermatosis
- Traditions
- traditional
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
Traditional use
- carminative
- dermatosis
- fever
- philter
- swelling
- tympanitis
What the science says
- The study found that Aristolochia tagala in Homnawakod herbal formula did not cause acute nephrotoxicity or worsen LPS-induced organ injuries in rats at the tested doses.
- The study found that extracts from Aristolochia tagala and Curcuma caesia showed antioxidant, anti-inflammatory, and anticancer activity possibly through TNF-α-mediated decrease in NF-κB binding activity.
- The methanolic extracts of Aristolochia tagala and Curcuma caesia showed potential anti-carcinogenic and antioxidant effects in mice exposed to diethylnitrosamine.
- Aristolochia tagala was documented as one of 35 medicinal plant species used by Kani tribes for various ailments in Thodu hills, Kerala.
Frequently asked questions
What is Aristolochia tagala?
Aristolochia tagala (Aristolochia tagala) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What is Aristolochia tagala traditionally used for?
Traditional sources record Aristolochia tagala for: carminative, dermatosis, fever, philter, swelling, tympanitis. This reflects traditional use, not a proven medical treatment.
Which traditions use Aristolochia tagala?
Aristolochia tagala appears in these traditions in our sources: traditional.
What does the scientific evidence say about Aristolochia tagala?
4 sourced findings are recorded for Aristolochia tagala; the strongest carries evidence grade D. For example: The study found that Aristolochia tagala in Homnawakod herbal formula did not cause acute nephrotoxicity or worsen LPS-induced organ injuries in rats at the tested doses.
How strong is the evidence for Aristolochia tagala?
The strongest finding for Aristolochia tagala carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Aristolochia tagala safe? What are the side effects?
No major safety issues are recorded for Aristolochia tagala in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Aristolochia tagala interact with medications?
No drug interactions are recorded for Aristolochia tagala in our sources. This does not rule them out — check with a pharmacist.
Is Aristolochia tagala a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T3 Dr. Duke's Ethnobotanical Database public domain (USDA ARS — attribute Dr. Duke's)
- T2 The safety of Homnawakod herbal formula containing Aristolochia tagala Cham. in Wistar rats. literature abstract metadata
- T2 Ethnobotanical study of Kani tribes in Thoduhills of Kerala, South India. literature abstract metadata
- T2 Inhibitory potential of methanolic extracts of Aristolochia tagala and Curcuma caesia on hepatocellular carcinoma induced by diethylnitrosamine in BALB/c mice. literature abstract metadata
- T2 Phytochemicals of Aristolochia tagala and Curcuma caesia exert anticancer effect by tumor necrosis factor-α-mediated decrease in nuclear factor kappaB binding activity. literature abstract metadata